BACKGROUND: Chromosome 9p21 variants are among the most robust genetic markers for coronary artery disease (CAD), and previous studies have suggested that genetic effects of this locus might be modified by dietary factors. Intake of sugar-sweetened beverages (SSBs), which are the main dietary source of added sugar, has been shown to interact with genetic factors in affecting CAD risk factors such as obesity. OBJECTIVE: We aimed to test whether SSB intake modified the association between chromosome 9p21 variants and CAD risk in Hispanics living in Costa Rica. DESIGN: The current study included 1560 incident cases of nonfatal myocardial infarction (MI) and 1751 population-based controls. Three independent single nucleotide polymorphisms (SNPs) at the chromosome 9p21 locus were genotyped. SSB intake was assessed with the use of a food-frequency questionnaire and was defined as the frequency of intake of daily servings of sweetened beverages and fruit juice. RESULTS: We showed a significant interaction between SSB intake and one of the 3 variants (i.e., rs4977574) on MI risk. The per–risk allele OR (95% CI) of rs4977574 for MI was 1.44 (1.19, 1.74) in participants with higher SSB consumption (>2 servings/d), 1.21 (1.00, 1.47) in those with average consumption (1–2 servings/d), and 0.97 (0.81, 1.16) in subjects with lower consumption (<1 serving/d; P-interaction = 0.005). A genetic risk score derived from the sum of risk alleles of the 3 SNPs also showed a significant interaction with SSB intake on MI risk (P-interaction = 0.03). CONCLUSION: Our data suggest that unhealthy dietary habits such as higher intake of SSBs could exacerbate the effects of chromosome 9p21 variants on CAD.
BACKGROUND: Chromosome 9p21 variants are among the most robust genetic markers for coronary artery disease (CAD), and previous studies have suggested that genetic effects of this locus might be modified by dietary factors. Intake of sugar-sweetened beverages (SSBs), which are the main dietary source of added sugar, has been shown to interact with genetic factors in affecting CAD risk factors such as obesity. OBJECTIVE: We aimed to test whether SSB intake modified the association between chromosome 9p21 variants and CAD risk in Hispanics living in Costa Rica. DESIGN: The current study included 1560 incident cases of nonfatal myocardial infarction (MI) and 1751 population-based controls. Three independent single nucleotide polymorphisms (SNPs) at the chromosome 9p21 locus were genotyped. SSB intake was assessed with the use of a food-frequency questionnaire and was defined as the frequency of intake of daily servings of sweetened beverages and fruit juice. RESULTS: We showed a significant interaction between SSB intake and one of the 3 variants (i.e., rs4977574) on MI risk. The per–risk allele OR (95% CI) of rs4977574 for MI was 1.44 (1.19, 1.74) in participants with higher SSB consumption (>2 servings/d), 1.21 (1.00, 1.47) in those with average consumption (1–2 servings/d), and 0.97 (0.81, 1.16) in subjects with lower consumption (<1 serving/d; P-interaction = 0.005). A genetic risk score derived from the sum of risk alleles of the 3 SNPs also showed a significant interaction with SSB intake on MI risk (P-interaction = 0.03). CONCLUSION: Our data suggest that unhealthy dietary habits such as higher intake of SSBs could exacerbate the effects of chromosome 9p21 variants on CAD.
Authors: Anna Helgadottir; Gudmar Thorleifsson; Andrei Manolescu; Solveig Gretarsdottir; Thorarinn Blondal; Aslaug Jonasdottir; Adalbjorg Jonasdottir; Asgeir Sigurdsson; Adam Baker; Arnar Palsson; Gisli Masson; Daniel F Gudbjartsson; Kristinn P Magnusson; Karl Andersen; Allan I Levey; Valgerdur M Backman; Sigurborg Matthiasdottir; Thorbjorg Jonsdottir; Stefan Palsson; Helga Einarsdottir; Steinunn Gunnarsdottir; Arnaldur Gylfason; Viola Vaccarino; W Craig Hooper; Muredach P Reilly; Christopher B Granger; Harland Austin; Daniel J Rader; Svati H Shah; Arshed A Quyyumi; Jeffrey R Gulcher; Gudmundur Thorgeirsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson Journal: Science Date: 2007-05-03 Impact factor: 47.728
Authors: Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong Journal: Circulation Date: 2008-12-15 Impact factor: 29.690
Authors: Lance A Bare; Edward A Ruiz-Narvaéz; Carmen H Tong; Andre R Arellano; Charles M Rowland; Joseph J Catanese; Frank M Sacks; James J Devlin; Hannia Campos Journal: PLoS One Date: 2010-09-29 Impact factor: 3.240
Authors: Martha L Daviglus; Gregory A Talavera; M Larissa Avilés-Santa; Matthew Allison; Jianwen Cai; Michael H Criqui; Marc Gellman; Aida L Giachello; Natalia Gouskova; Robert C Kaplan; Lisa LaVange; Frank Penedo; Krista Perreira; Amber Pirzada; Neil Schneiderman; Sylvia Wassertheil-Smoller; Paul D Sorlie; Jeremiah Stamler Journal: JAMA Date: 2012-11-07 Impact factor: 56.272
Authors: Ron Do; Changchun Xie; Xiaohe Zhang; Satu Männistö; Kennet Harald; Shofiqul Islam; Swneke D Bailey; Sumathy Rangarajan; Matthew J McQueen; Rafael Diaz; Liu Lisheng; Xingyu Wang; Kaisa Silander; Leena Peltonen; Salim Yusuf; Veikko Salomaa; James C Engert; Sonia S Anand Journal: PLoS Med Date: 2011-10-11 Impact factor: 11.069
Authors: Nicola M McKeown; Hassan S Dashti; Jiantao Ma; Danielle E Haslam; Jessica C Kiefte-de Jong; Caren E Smith; Toshiko Tanaka; Mariaelisa Graff; Rozenn N Lemaitre; Denis Rybin; Emily Sonestedt; Alexis C Frazier-Wood; Dennis O Mook-Kanamori; Yanping Li; Carol A Wang; Elisabeth T M Leermakers; Vera Mikkilä; Kristin L Young; Kenneth J Mukamal; L Adrienne Cupples; Christina-Alexandra Schulz; Tzu-An Chen; Ruifang Li-Gao; Tao Huang; Wendy H Oddy; Olli Raitakari; Kenneth Rice; James B Meigs; Ulrika Ericson; Lyn M Steffen; Frits R Rosendaal; Albert Hofman; Mika Kähönen; Bruce M Psaty; Louise Brunkwall; Andre G Uitterlinden; Jorma Viikari; David S Siscovick; Ilkka Seppälä; Kari E North; Dariush Mozaffarian; Josée Dupuis; Marju Orho-Melander; Stephen S Rich; Renée de Mutsert; Lu Qi; Craig E Pennell; Oscar H Franco; Terho Lehtimäki; Mark A Herman Journal: Diabetologia Date: 2017-11-02 Impact factor: 10.460
Authors: M Abdullah Said; Yordi J van de Vegte; Muhammad Mobeen Zafar; M Yldau van der Ende; Ghazala Kaukab Raja; N Verweij; Pim van der Harst Journal: Curr Cardiol Rep Date: 2019-07-27 Impact factor: 2.931
Authors: Danielle E Haslam; Nicola M McKeown; Mark A Herman; Alice H Lichtenstein; Hassan S Dashti Journal: Front Endocrinol (Lausanne) Date: 2018-01-08 Impact factor: 5.555